Q/C Technologies, Inc. Increase Decrease In Operating Lease Liability
Q/C Technologies, Inc. (QCLS) reported Increase Decrease In Operating Lease Liability of -$14.62 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-12
- Q/C Technologies, Inc. increase decrease in operating lease liability for the quarter ending 2024-12-31 was $0.00.
- Q/C Technologies, Inc. increase decrease in operating lease liability for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Q/C Technologies, Inc. increase decrease in operating lease liability for the quarter ending 2023-12-31 was -$746.00, a 277.20% decline year-over-year.
- Q/C Technologies, Inc. increase decrease in operating lease liability for the quarter ending 2023-09-30 was $6.00, a 98.92% decline year-over-year.
- Q/C Technologies, Inc. increase decrease in operating lease liability for fiscal 2024 was -$1.48K.
- Q/C Technologies, Inc. increase decrease in operating lease liability for fiscal 2023 was -$578.00, a 130.15% decline from fiscal 2022.
- Q/C Technologies, Inc. increase decrease in operating lease liability for fiscal 2022 was $1.92K.
- Q/C Technologies, Inc. increase decrease in operating lease liability for fiscal 2021 was -$81.00.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$14.62K 10-Q · filed 2026-08-12 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $0.00 derived: sum of 2 quarters · filed 2026-04-15 | -$1.48K 10-K · filed 2026-04-15 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$1.48K 10-Q · filed 2025-11-19 | ||
| 2024-06-30 | -$1.48K 10-Q · filed 2025-08-19 | |||
| 2023-12-31 | -$746.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-11 | -$740.00 derived: sum of 2 quarters · filed 2025-04-11 | -$735.00 derived: sum of 3 quarters · filed 2025-04-11 | -$578.00 10-K · filed 2025-04-11 |
| 2023-09-30 | $6.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $11.00 derived: sum of 2 quarters · filed 2024-11-14 | $168.00 10-Q · filed 2024-11-14 | $589.00 derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $5.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $162.00 10-Q · filed 2024-08-19 | $583.00 derived: sum of 3 quarters · filed 2024-08-19 | $1.14K derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $157.00 10-Q · filed 2023-05-15 | $578.00 derived: sum of 2 quarters · filed 2024-04-01 | $1.13K derived: sum of 3 quarters · filed 2024-04-01 | $1.68K derived: sum of 4 quarters · filed 2024-04-01 |
| 2022-12-31 | $421.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $974.00 derived: sum of 2 quarters · filed 2024-04-01 | $1.52K derived: sum of 3 quarters · filed 2024-04-01 | $1.92K 10-K · filed 2024-04-01 |
| 2022-09-30 | $553.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.10K derived: sum of 2 quarters · filed 2023-11-14 | $1.50K 10-Q · filed 2023-11-14 | $959.00 derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $547.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $943.00 10-Q · filed 2023-08-14 | $406.00 derived: sum of 3 quarters · filed 2023-08-14 | $584.00 derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $396.00 10-Q · filed 2023-05-15 | -$141.00 derived: sum of 2 quarters · filed 2023-05-15 | $37.00 derived: sum of 3 quarters · filed 2023-05-15 | $196.00 derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$537.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$359.00 derived: sum of 2 quarters · filed 2023-03-31 | -$200.00 derived: sum of 3 quarters · filed 2023-03-31 | -$81.00 10-K · filed 2023-03-31 |
| 2021-09-30 | $178.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $337.00 derived: sum of 2 quarters · filed 2022-11-10 | $456.00 10-Q · filed 2022-11-10 | $514.00 derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $159.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $278.00 10-Q · filed 2022-08-15 | $336.00 derived: sum of 3 quarters · filed 2022-08-15 | -$1.93K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $119.00 10-Q · filed 2022-05-16 | $177.00 derived: sum of 2 quarters · filed 2022-05-16 | -$2.09K derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $58.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | -$2.21K derived: sum of 2 quarters · filed 2022-03-31 | -$1.16K 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$2.27K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2021-11-15 | -$1.21K 10-Q/A · filed 2021-11-15 | ||
| 2020-06-30 | $1.06K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |